Introduction Shanghai Mianyi Biotechnology Co., Ltd., established on June 30, 2017, operates as a wholly-owned subsidiary of Belief Pharmaceutical Technology (Shanghai) Co., Ltd., under the parent company Belief BioMed Inc. This high-tech corporation specializes in the development, manufacturing, and clinical application of gene therapy products. Shanghai Mianyi Biotechnology Co., Ltd. is dedicated to delivering pioneering gene therapies for age-related disorders, cancers, and monogenic hereditary diseases, leveraging secure and potent viral vector technologies. |